Topic

Articles

The need for specific capabilities to suit DCT business models is creating new challenges in team building, training, and development.

Creating Future-Ready Teams for Digital Clinical Trials

Decentralized vs Digital Clinical Trials: There is a Difference

Dave Hanaman, Co-founder of Curavit, discusses his perspectives on decentralized clinical trials.

Insights into Definining Decentralized Clinical Trials

Five therapeutic areas that are apt for an all-virtual approach, and that can serve as an entry point for sponsors who are hesitant yet interested in exploring the growing DCT model.

Decentralized Clinical Trials: What Therapeutic Areas are Ripe for All-Virtual?

This article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the center and enables active monitoring, before the onset of clinical events, leading to improved healthcare. 

Opportunities for Improving Clinical Decisions with Patient Centric Remote Blood Sampling Approaches

Guidance on the unique challenges presented by electronic outcomes.

Perspectives and Guidance for Effective eCOA in Global DCTs

Consultant, International Drug Development Institute (IDDI)

Using the promising-zone approach can salvage an underpowered trial.

Sample Size Re-Estimation as an Adaptive Design 

Industry set to make choice on whether COVID-19 trials are the new standard.

The Future of Clinical Trial Design Looks Bright

Strategies and considerations for adopting decentralized clinical trials. 

Five Key Considerations for Designing and Implementing Decentralized Clinical Trials

A look at some of the leading causes of study failure and explain how improving medication adherence could be the key to risk mitigation.